KOSDAQFood & Beverage277410

Insan

₩4,615▲ 1.54%2026-11-18 close
Market Cap
₩17.7B
Turnover
₩7,171,295
Volume
1.6K
Shares out.
3.8M
PER
12.9×
PBR
0.3×
EPS
₩364
Dividend Yield
4.27%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩200 per share · Prices as of the 2026-11-18 close

01

Report overview

Jukyeom Core Recovers, Profit Durability Under Test

Insan's operating profit recovered to KRW 2.31 billion in 2025, but quarterly operating profit has hovered around KRW 300 million through the first three quarters of 2026, making earnings durability the next checkpoint.

  1. 1

    The 2025 operating margin recovered to 6.4% from 2.5% in 2024 but remains below the 15.4% recorded in 2023.

  2. 2

    The flagship ninth-generation Jukyeom product grew 22% to KRW 11.4 billion in 2025 and drove results, but the reliance on one product line is a structural feature.

  3. 3

    First-half 2026 sales rose year on year while operating results swung to a loss, and third-quarter sales fell 5.6% from a year earlier.

  4. 4

    Net profit attributable to controlling shareholders fell for a second straight year to KRW 652 million in 2025, and the company attributed part of the decline to derivative valuation effects.

  5. 5

    The next periodic report is the 2026 annual report; the annual preliminary results expected in early February 2027 and the operating status of the new Jukyeom plant are the next checkpoints.

02

Business structure

Insan has produced Jukyeom (bamboo salt) and related processed foods since the founding of Insan Foods in 1987. It was incorporated as Insan Co., Ltd. in 1992 after absorbing Insan Foods, and listed on KOSDAQ in 2018 through a merger with a special purpose acquisition company.

Its two subsidiaries are Insan Farm and Insan Healthcare. The core products are Jukyeom and Jukyeom-based processed foods, supplemented by traditional extract and pill-type products.

The flagship ninth-generation Jukyeom product generated KRW 11.4 billion in annual sales in 2025, up 22% year on year, and drove overall results. The company is broadening its premium ready-meal (HMR) lineup built around Jukyeom, including ginseng chicken soup, seaweed soup, side dishes and loach soup.

Sales channels include company-operated stores, the company's own online mall, member-only sales and home shopping. In late January 2026, the company said a Jukyeom-based grilled fish product sold all 71,500 packs within about 30 minutes of a home-shopping broadcast starting.

The company has recently launched a new network-marketing business, and the cost burden from it was cited as a factor that weakened profitability in the first half of 2026.

Jukyeom is positioned as a differentiated traditional product, and consumer demand for health- and quality-focused food supports demand for premium salt.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩10.9B₩1.7B15.2%
2025Q4₩8.8B₩300M3.9%
2026Q1₩10B-₩300M−3.3%
2026Q2₩9.9B₩300M3.3%
2026Q3₩10.3B₩400M3.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩33.5B₩4.7B₩3.8B14.0%7.3%67.2%
2023₩37.3B₩5.7B₩5B15.4%7.6%38.0%
2024₩32.5B₩800M₩900M2.5%1.4%55.1%
2025₩35.8B₩2.3B₩700M6.4%1.0%74.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On an annual basis, revenue rose from KRW 33.5 billion in 2022 to KRW 37.3 billion in 2023 (up 11.2% year on year), fell to KRW 32.5 billion in 2024 (down 12.9%), and recovered to KRW 35.8 billion in 2025 (up 10.2%). Among 2022 to 2025, 2023 was the largest year for revenue and 2024 the smallest.

Operating profit moved from KRW 4.7 billion in 2022 to KRW 5.74 billion in 2023 (up 22.0%), then KRW 814 million in 2024 (down 85.8%), and KRW 2.31 billion in 2025 (up 183.4%).

The operating margin was 14.0%, 15.4%, 2.5% and 6.4% in 2022 through 2025, so it has recovered from the 2024 low but remains below the 2023 level.

Net profit attributable to controlling shareholders was KRW 3.77 billion in 2022, KRW 4.97 billion in 2023 (up 31.6%), KRW 887 million in 2024 (down 82.1%) and KRW 652 million in 2025 (down 26.6%). 2023 was the peak, and the figure declined in both 2024 and 2025.

Net profit including non-controlling interests, which is a separate figure, was KRW 637 million in 2025. The company said part of the 2025 decline reflected derivative valuation effects linked to its bond with warrants.

Operating cash flow swung from a net outflow of KRW 987 million in 2024 to an inflow of KRW 1.17 billion in 2025. The debt-to-equity ratio rose from 38.0% in 2023 to 55.1% in 2024 and 74.1% in 2025.

At the end of 2025, total equity was KRW 65.6 billion, equity attributable to controlling shareholders was KRW 65.3 billion, and total liabilities were KRW 48.6 billion.

Quarterly results show that after KRW 10.9 billion in sales and KRW 1.66 billion in operating profit in the third quarter of 2025, the fourth quarter brought KRW 8.75 billion in sales (down 20.0% from the prior quarter) and KRW 342 million in operating profit (down 79.4%).

The first quarter of 2026 swung to an operating loss of KRW 328 million on KRW 9.99 billion in sales, and the second quarter returned to operating profit of KRW 323 million on KRW 9.92 billion in sales.

Third-quarter 2026 sales were KRW 10.3 billion (down 5.6% year on year) and operating profit was KRW 360 million (down 78.3%).

Net profit attributable to controlling shareholders in the second and third quarters of 2026 was KRW 872 million and KRW 657 million, well above operating profit, which points to a large non-operating effect.

The sum of net profit attributable to controlling shareholders over the latest four quarters is KRW 1.38 billion.

05

Industry analysis

Korea's salt market has grown gradually. Industry data cited by a 2020 securities report based on the food safety ministry's production statistics show that salt-product sales rose from KRW 1.37 billion in 2015 to KRW 1.47 billion in 2019, an average annual increase of 1.4%.

That data predates 2020 and does not describe the current market size, but it serves as a baseline for the growth pace of a basic food category. Within salt products, Jukyeom sits in the premium segment.

An information site's analysis as of September 2026 said consumer preference for health- and quality-focused food is broadening demand for premium salt. Premium ready-meals (HMR) and home shopping are the main downstream channels through which Jukyeom-based products reach consumers.

In competitive terms, Insan differentiates itself through the Jukyeom product itself and a manufacturing tradition passed down over four generations. The same structure is also a weakness, because results depend heavily on one product line, so its sales trend directly determines company-wide revenue.

The earnings swings, from the 2024 low to the 2025 recovery and the first-half 2026 loss, were driven largely by company-specific factors such as new-business costs and organizational restructuring.

06

Outlook

The company has said that the effects of restructuring its sales organization and sales structure since the second half of 2025 have accumulated over the year, and that its profit structure is now improving in earnest.

The company describes the results as the outcome of a medium- to long-term structural improvement rather than a one-off rebound, and emphasizes operating efficiency and stronger quality control.

On the production side, reports from 2024 described a KRW 30.5 billion new Jukyeom manufacturing plant in Hamyang, South Gyeongsang, which would quadruple production capacity once completed. An August 2025 report said the new plant was planned for completion within that year.

Information on when the plant begins operating and how it contributes to revenue is limited, so disclosures in the 2026 annual report on facilities and sales are the next checkpoint. On financing, the company approved a KRW 15 billion bond with warrants in 2024 to fund facility investment.

Derivative valuation of this instrument can swing non-operating results and remains a source of net profit volatility. How quickly the costs of the new network-marketing business are absorbed will be a key variable for operating profit in the second half of 2026. Strong sales of flagship products through home shopping can be read as a positive sign for channel expansion.

07

Valuation

PER
12.9×
PBR
0.3×
ROE
2.1%
EPS
₩364
BPS
₩17,291
Dividend per share
₩200

Valuation is easier to read when earnings-based and asset-based measures are considered separately. A market information site's tally as of early September 2026 showed a P/E above the industry average, but that multiple is based on 2025 reported earnings and moves sharply when profit is small.

Operating profit rose 183.4% in 2025, while the first half of 2026 returned to an operating loss, so the multiple is sensitive to assumptions about profit. On an asset basis, the price-to-book ratio is below 1x, which means the shares trade at a discount to net asset value.

Total equity at the end of 2025 was KRW 65.6 billion, well above the current market capitalization, and how far the market credits that asset value depends on whether the operating profit recovery continues.

The company pays a year-end cash dividend, and the related agenda was approved at the shareholders' meeting on March 24, 2026. Because the company said derivative valuation affected 2025 net profit, the treatment of such one-off items also matters when interpreting the multiple.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Operating margin recovery

The operating margin rose from 2.5% in 2024 to 6.4% in 2025, and operating profit grew 183.4% to KRW 2.31 billion. The company attributes this to the cumulative effect of restructuring its sales organization since the second half of 2025. Revenue also grew 10.2% to KRW 35.8 billion, so volume and profitability improved together.

Flagship product and channel expansion

The flagship ninth-generation Jukyeom product generated KRW 11.4 billion in 2025, up 22%. The Jukyeom-based HMR lineup has been widened to include ginseng chicken soup, seaweed soup, side dishes and loach soup.

The company said a Jukyeom-based grilled fish product sold 71,500 packs within about 30 minutes of a home-shopping broadcast in late January 2026.

Planned capacity expansion and equity base

A KRW 30.5 billion new Jukyeom plant in Hamyang, South Gyeongsang has been reported, and it would quadruple production capacity once completed. Total equity at the end of 2025 was KRW 65.6 billion, with KRW 65.3 billion attributable to controlling shareholders. A larger production base could reduce supply constraints if demand for the flagship products rises.

09

Bear factors

Return to operating loss in first half of 2026

Operating results were a loss of KRW 328 million in the first quarter of 2026, a profit of KRW 323 million in the second quarter and a profit of KRW 360 million in the third quarter. Third-quarter operating profit fell 78.3% year on year and sales fell 5.6%.

Although first-half 2026 sales rose from a year earlier, operating results swung to a loss in one tally, so sales growth has not carried through to profit.

Cost burden from new business

An information site noted that costs tied to the new network-marketing business weakened profitability. Over the same period, demand for premium salt grew as consumers focused on health and quality.

Revenue drivers and cost drivers are pulling in opposite directions, so how quickly new-business costs decline is the key question.

Profit decline and rising leverage

Net profit attributable to controlling shareholders fell for two straight years, to KRW 887 million in 2024 (down 82.1%) and KRW 652 million in 2025 (down 26.6%). The debt-to-equity ratio rose from 38.0% in 2023 to 55.1% in 2024 and 74.1% in 2025. Operating cash flow was a net outflow of KRW 987 million in 2024.

10

Risk factors

Accounting volatility (derivatives)

The company said that derivative valuation of its bond with warrants issued in 2024 weighed on 2025 net profit. Valuation gains and losses unrelated to operations can strongly influence profit attributable to controlling shareholders.

In the second and third quarters of 2026, that figure was well above operating profit, so non-operating items remain large.

Product and channel concentration

Results depend heavily on Jukyeom products, especially the ninth-generation product, so the sales trend of one product largely determines company-wide revenue. The sales mix also relies on home shopping and company-operated stores, which makes results sensitive to broadcast scheduling and channel policy. A drop in one channel could widen quarterly swings.

Investment and borrowing burden

A KRW 30.5 billion new plant has been planned, and a separate KRW 25.4 billion facility investment was reported in 2024. The company issued a KRW 15 billion bond with warrants to fund facility spending. The debt-to-equity ratio was 74.1% at the end of 2025, compared with 38.0% in 2023.

11

What to watch next

  1. Early February 2027

    Preliminary 2026 annual results. The 2025 preliminary figures were released on February 3, 2026. Whether the 6.4% operating margin of 2025 holds, and how the first-half 2026 loss was offset in the second half, are the points to check.

  2. March 2027

    Filing of the 2026 annual report and the regular shareholders' meeting. The prior year's meeting was held on March 24, 2026. Items to check include the operating status of the new Jukyeom plant, derivative valuation effects from the bond with warrants, and operating cash flow.

  3. Mid-May 2027

    Filing of the first-quarter 2027 report. Points to check are how much of the new network-marketing business costs remain in quarterly operating profit and whether flagship product sales hold quarterly revenue levels.

12

Overall view

Insan's operating margin recovered from 2.5% in 2024 to 6.4% in 2025, and revenue grew to KRW 35.8 billion. The flagship ninth-generation Jukyeom product sits at the center of results and drove the recovery, but the reliance on one product line is a structural feature.

Sales rose in the first half of 2026, yet operating results swung to a loss, and third-quarter operating profit fell 78.3% year on year. Net profit attributable to controlling shareholders declined for two straight years, and the company partly attributed this to derivative valuation effects.

On an asset basis, total equity was KRW 65.6 billion at the end of 2025, and the price-to-book ratio is below 1x. The debt-to-equity ratio rose to 74.1% in 2025, and a new plant investment is planned.

The next checkpoints are the preliminary 2026 annual results in early February 2027, the 2026 annual report and shareholders' meeting in March 2027, and the first-quarter 2027 report in mid-May 2027. This material is provided for information only and should be read alongside the original disclosures.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.fnguide.com
  2. comp.wisereport.co.kr
  3. ssl.pstatic.net
  4. paxnet.co.kr
  5. ssl.pstatic.net
  6. ssl.pstatic.net
  7. m.news.nate.com
  8. edaily.co.kr
  9. securities.miraeasset.com
  10. edaily.co.kr
  11. m.news.nate.com
  12. markets.hankyung.com
  13. judal.co.kr
  14. judal.co.kr
  15. pflow.keywordegg.com
  16. orgo.kr
  17. littlebproject.com
  18. judal.co.kr

Report written 2026-11-13 · Data as of 2026-11-12

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis